What Criteria Determine Substantive Pharma Influence Over Content on Social Media Sites? Survey says…
In preparation for FDA's public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools, the...
FDA Letters Caused a Prompt, Precipitous, & Prolonged Drop in Pharma Paid Search Engine...
A comScore study found that "sponsored link exposures to U.S. Internet users declined more than 50 percent immediately after ... FDA warning letters were...
My Opinion of Google’s Decision to Foist Sidewiki Upon Us
Instead of "Victory Through Hare Power" as the book title in the following clip, think "Victory Through Sidewiki Power."
For details, see "Google's Wacky Wiki...
Reminder DTC Ads OK in Canada, Not in US. What’s Up With That?
According to Marketing News, Pfizer Canada just launched a 15-second TV ad that promotes Viagra as "an antidote for couples that choose leisurely pastimes...
Risk Mitigation and Its Impact on Pharma Marketing: Appropriate Use Benefits After Launch
Risk management, REMS, danger management of your product's life cycle, whatever you call it, all are crucial to brand managers and marketing executives. This article summarizes Fetterman's ideas about how to develop a REMS that can be a win-win-win situation for you, your product, and the patient.
Pharmaceutical Market Access 2010: Strategic Developments Impacting the US, EU, and Emerging Markets
Future revenue growth in the US and EU will be limited as the EU wrestles with cost effectiveness and the US debates healthcare reforms. Meanwhile, pharma and biotech companies are looking to emerging market opportunities in Brazil, Russia, India, and China (i.e., BRIC) to drive future business. What does this all mean for patients, physicians, payers, and pharmaceutical/biotech manufacturers? This article addresses that question.
Social Media Adverse Event Reporting Safe Harbors: It’s Time for FDA to Open Up...
This article presents ideas for regulatory 'safe harbors' under which pharmaceutical companies would be relieved of the responsibility of monitoring social media for adverse events. Includes a detailed summary of responses to the survey 'FDA Regulation of Drug & Device Promotion via the Internet & Social Media' regarding social media adverse event monitoring, processing, challenges, and uncertainties.
Pharma Marketing News Vol. 8, #9
Welcome to the October 2009 issue of Pharma Marketing News.
Pharma Marketing News Vol. 8, #9
Welcome to the October 2009 issue of Pharma Marketing News.
Google’s Wacky Wiki is Whack! Pharma Should Demand Ability to Block It!
Have you heard of sidewiki? Sidewiki is Google's new browser sidebar that "enables you to contribute and read helpful information alongside any web page....
